Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
about
Tremelimumab-Induced Graves Hyperthyroidism.Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy.Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
P2860
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
@en
type
label
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
@en
prefLabel
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
@en
P2093
P2860
P356
P1476
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma
@en
P2093
Amy Joehlin-Price
David Liebner
Fadi Nabhan
Umal Azmat
P2860
P304
P356
10.1155/2016/2087525
P50
P577
2016-01-11T00:00:00Z